According to a report in the Daily Telegraph this morning, there is significant variation is prostate cancer mortality rates across England.
Filed under: Uncategorized | Tagged: England, mortality, rate | 11 Comments »
US federal judge invalidates gene patents
Posted on March 30, 2010 by Sitemaster
In a case that has major ramifications for the health care industry and for personalized medicine, a federal judge in New York yesterday invalidated the patents on BRAC1 and BRAC2 genes held by Myriad Genetics and the University of Utah.
Filed under: Diagnosis, Management, Prevention, Risk, Treatment | Tagged: gene, patent, test | 1 Comment »
Prostate cancer news reports: Tuesday, March 30, 2010
Posted on March 30, 2010 by Sitemaster
Today’s news reports address: Diabetes and prostate cancer risk among Japanese men The accuracy of T2w ecMRI in detection of prostate cancer Escalated dose radiation therapy and treatment of localized prostate cancer Erectile dysfunction and penile rehabilitation post-surgery
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diabetes, endorectal coil, erectile dysfunction, MRI, penile rehabilitation, radiotherapy, risk | Leave a Comment »
GSK resubmits data for approval of dutasteride to prevent prostate cancer
Posted on March 29, 2010 by Sitemaster
According to a media release earlier today, GlaxoSmithKline (GSK) has resubmitted data to the U.S. Food and Drug Administration (FDA) in support of the approval to market dutasteride (Avodart) as a drug to reduce the risk for prostate cancer among men believed to be at high risk.
Filed under: Prevention, Risk | Tagged: dutasteride, Prevention, risk | 1 Comment »
Should prostate cancer patients start doing Kegels before surgery?
Posted on March 29, 2010 by Sitemaster
The “New” Prostate Cancer InfoLink has always believed that preoperative training of the pelvic floor muscles (using Kegel exercises) would be likely to improve recovery of continence after radical prostatectomy,
Filed under: Living with Prostate Cancer, Management | Tagged: Kegel exercises, plevic floor muscle, surgery, training | 3 Comments »
Prostate cancer news reports: Monday, March 29, 2010
Posted on March 29, 2010 by Sitemaster
News reports over the weekend included: Various review articles dealing with such matters as Gleason grading, numbers of cores taken at biopsy, the need for lymph node dissection, surgical technique and surgical margin control, and cryotherapy The effect of a water extract of white cocoa tea on prostate cancer cells in vitro and in a [...]
Filed under: Diagnosis, Management, Treatment | Tagged: biopsy, cryotherapy, Gleason grading, lymph node dissection, surgical margins, surgical technique, white cocoa tea | Leave a Comment »
U.S. health care reform and prostate cancer — today and tomorrow
Posted on March 27, 2010 by Sitemaster
Neither The “New” Prostate Cancer InfoLink nor the vast majority of Americans really look at the recent health care reform controversy as “all good” or “all bad.”
Filed under: Diagnosis, Living with Prostate Cancer, Prevention | Tagged: América, health, reform | Leave a Comment »
Post-treatment mortality of elderly men with high-risk prostate cancer
Posted on March 26, 2010 by Sitemaster
New data from a series of > 700 elderly patients with high-risk prostate cancer suggests that aggressive combination therapy for such men is associated with a reduced risk for prostate cancer-specific mortality.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", ADT, androgen deprivation therapy, brachytherapy, elderly, external beam radiation therapy, mortality | Leave a Comment »
Dynamic adaptive radiation therapy: an introduction
Posted on March 24, 2010 by Sitemaster
The two terms “adaptive radiation therapy” and “dynamic adaptive radiation therapy” are likely to become much more commonly used in the next few years as the use of these techniques expand out from academic and highly specialized radiotherapy centers into the community setting.
Filed under: Management, Treatment | Tagged: adaptive, Calypso, dynamic, radiation therapy | 1 Comment »
“May” is a word custom-made to mislead us
Posted on March 23, 2010 by Sitemaster
Every year thousands of published research papers and articles carefully use the word “may” or “could” in a headline or a conclusion … and can lead to misconceptions and misunderstandings as a consequence. There are two perfect examples from today’s news.
Filed under: Diagnosis, Prevention, Risk | Tagged: diet, infertility, risk, walnuts | 3 Comments »
Hormone therapy effective in man with PSA > 21,000, but …
Posted on March 22, 2010 by Sitemaster
An article in just published in Onkologie reports the diagnosis and (short-term) treatment of widely disseminated, metastatic prostate cancer in a 64-year-old Croatian man with a PSA of > 21,000 ng/ml.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: hormone therapy, PSA, survival, timing | 4 Comments »
How preconceptions impact prostate cancer management
Posted on March 20, 2010 by Sitemaster
As Leah wrote in a comment on this blog just the other day, “Yes, the ‘D-word’ is still taboo. Death is UNAMERICAN.” The comment stimulated the thought that our preconceptions have significant impact on how we think about risk, diagnosis, and treatment of prostate cancer — and yet there is really very little good research on [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: decision-making, knowledge, Management, perception, Treatment | 26 Comments »
Active surveillance for prostate cancer: an NCCN update
Posted on March 18, 2010 by Sitemaster
In a long media release today, the National Comprehensive Cancer Network (NCCN) encapsulated a presentation at the NCCN’s 15th Annual Conference by Dr. James L. Mohler, in which he discussed the role of active surveillance and other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, guidelines, NCCN, Treatment | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
